• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.01%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    553.66 Up 6.56(1.20%) Jul 31, 4:00PM EDT
    |After Hours : 554.00 Up 0.34 (0.06%) Jul 31, 6:42PM EDT
    Add to Portfolio
    Prev Close:547.10
    Open:551.29
    Bid:550.32 x 100
    Ask:N/A
    1y Target Est:535.04
    Beta:1.03
    Next Earnings Date: 4-Aug-15REGN Earnings announcement
    Day's Range:547.85 - 558.50
    52wk Range:314.00 - 569.91
    Volume:501,079
    Avg Vol (3m):722,645
    Market Cap:58.27B
    P/E (ttm):177.63
    EPS (ttm):3.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    REGNUp 1.20%58.27B
    AMGNUp 2.85%134.27B
    NVSUp 0.55%250.57B
    RHHBYUp 0.17%245.91B

    Key Statistics

    Forward P/E (1 yr):40.53
    P/S (ttm):18.26
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :11.15
    Quarterly EPS Est (Jun-15) :2.77
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):2.30

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback